APOBEC3B and neoplasm: Long-lived APOBEC3B-high tumor cells, even when still dormant, will have more opportunities to accumulate mutations, evolve, escape the dormant state, outgrow, metastasize, and potentially acquire resistance during additional rounds of therapy.